The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis; UCB
Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
 
Helen H. Moon
Honoraria - EMD Serono; Pfizer/EMD Serono
Research Funding - Amgen (Inst); Apollomics (Inst); Arcus Biosciences (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); HUYA Bioscience International (Inst); Nektar (Inst); Prometheus; Revimmune (Inst); Revimmune (Inst); Revimmune (Inst); Seagen (Inst); Xenocor
Travel, Accommodations, Expenses - Aveo; Bayer; Seagen
 
Mairead Kearney
No Relationships to Disclose
 
Seyed Hamidreza Mahmoudpour
Employment - Merck KGaA
 
Chiemeka Ike
Employment - EMD Serono
Stock and Other Ownership Interests - EMD Serono
 
Valerie A. Morris
Employment - EMD Serono
 
Andrew Rava
Employment - Genesis Research
 
Sonia Kim
Employment - Genesis Research
 
Haiyan Sun
Employment - Genesis Research
 
Marley Boyd
Employment - Genesis Research
 
Gabriel Gomez Rey
Employment - Genesis Research